Home » Topics » Regulatory » EMA

EMA
RSS

Protherics withdraws European application for Voraxaze

May 31, 2007

European CHMP recommends approval of Siklos

May 10, 2007

Pergoveris recommended for E.U. approval

May 9, 2007

Ariad receives FDA feedback on pivotal study of AP-23573 for metastatic sarcoma

April 11, 2007

Lilly withdraws E.U. marketing authorization application for Arxxant

April 10, 2007

EMEA recommends restrictions on use of Ketek

April 4, 2007

Orencia recommended for approval in E.U. for rheumatoid arthritis

April 2, 2007

European CHMP hands down positive opinions for Xyrem and Prevenar

Jan. 30, 2007

Sprycel approved in E.U.

Dec. 1, 2006

Microdosing/phase 0 trials: Paradigm shift aims to speed new drug development, improve efficiency

Nov. 7, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026